- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CT inventor Hounsfield dies at 84
Sir Godfrey N. Hounsfield, who won the 1979 Nobel Prize in Medicine for inventing computed axial tomography, died Aug. 12. He was 84. Hounsfield began work at EMI in Middlesex, U.K., in 1951 and retired in 1986. He conceived the idea for a CAT scanner in
Sir Godfrey N. Hounsfield, who won the 1979 Nobel Prize in Medicine for inventing computed axial tomography, died Aug. 12. He was 84. Hounsfield began work at EMI in Middlesex, U.K., in 1951 and retired in 1986. He conceived the idea for a CAT scanner in 1967. Early prototypes took nine days to scan an object. Processing the data took another 21 hours. By 1972, he had built a machine that produced detailed cross-sectional images of the brain in less than five minutes. Introducing Hounsfield at the Nobel presentations, Prof. Torgny Greitz of the Karolinska Medico-Chirurgical Institute, which chooses the recipients of the Nobel prize for physiology or medicine, said the first clinical results in the spring of 1972 changed the course of diagnostic medicine.
"Up to that time, ordinary x-ray examinations of the head had shown the skull bones, but the brain had remained a gray, undifferentiated fog. Now, suddenly, the fog had cleared," he said.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
